Contact us
Contact us to learn more about our Pediatric Epidermolysis Bullosa Clinic or to schedule an appointment.
Notice of West building lobby closure at Lucile Packard Children’s Hospital Stanford
A child with epidermolysis bullosa (EB) has an inherited skin disorder that causes blisters after even the mildest trauma. EB is never contagious because it is a genetic disease.
Most commonly, EB causes blisters on the skin, but EB can also affect the mouth, esophagus, lungs, muscles, eyes, nails and teeth.
There are four types of EB, all caused by different genetic mutations:
The effects of the disease can be mild, disabling, or life threatening and depend on the type of EB. EB simplex is the mildest and most common form of EB, while Junctional EB and Dystrophic EB are less common and can affect the patient more severely.
Based on statistics collected through the National Epidermolysis Bullosa Registry, EB is estimated to occur in 20 newborns per 1 million live births in the United States. The exact number of persons with EB is unclear, but estimates suggest that 25,000 - 50,000 people in the United States have EB.
Many people with mild forms of epidermolysis bullosa require less intense but careful skin care habits, such as gentle bathing and moisturizing, a plan to reduce blistering and improve wound healing, and daily habits that avoid friction on the skin that can lead to tearing.
Children and young adults with the most common form of epidermolysis bullosa, EB simplex (EBS), can have very mild symptoms or very severe symptoms. While people with very mild EBS may not need to seek medical help frequently later in life, it is hard to predict how severe their epidermolysis bullosa simplex will be during infancy and early childhood. Therefore, doctors treat EBS as if it is severe from the start, which includes providing care from many specialists to limit the risk of worsening symptoms later in life. Severe EB increases your/your child’s risk for infection, diseased organs, and skin cancer.
Hours of daily care are usually needed for someone with epidermolysis bullosa to stay healthy. For children, this care is often given by family members. EB care is similar to that of burn victims, requiring wrapping blisters and chronic wounds in bandages and changing bandages regularly. While this daily care is still needed, we now offer a chance at healing chronic wounds with our recent FDA-approved breakthrough treatments.
Stanford Medicine dermatologists have been researching epidermolysis bullosa for over 30 years and lead the nation in scientific discoveries. We have numerous ongoing EB clinical trials for different types of EB to find better ways to care for our patients.
In the early 2000s, our doctor-researchers developed a way to change a person’s skin cells with genetics. They showed that the changed skin could be grown into small sheets, about the size of a dollar, that had functioning collagen VII—the element in skin that was missing, and which creates strength and connected layers of skin.
Their research led to a number of clinical trials to develop and test gene therapies for children and young adults with severe epidermolysis bullosa. In 2023, Stanford Medicine’s first gene therapy—a topical gel—was shown to be both effective and safe, earning FDA approval. Just two years later, a skin graft therapy originating from Stanford also received FDA approval. We are proud to offer you/your child these effective treatments, which are seldom available elsewhere.
At Stanford Children’s, we support you in learning how to provide daily care for epidermolysis bullosa. This includes learning how to wrap and change bandages to keep your/your child’s skin as healthy as possible. We offer well-rounded whole-child/person care to help with nutritional, psychological, and social needs for you/your child and your family, as well as physical and occupational therapy, when needed.
Our goals for your/your child’s epidermolysis bullosa wound care include:
|
|
There are many types of EB Simplex. Most are caused by an autosomal dominant genetic mutation that leads to a defective keratin protein. Keratin proteins function as the scaffolding for the skin. When this scaffolding is not formed correctly, the skin is more likely to fall apart and form blisters.
EB Simplex can be split up into two main types, Generalized and Localized. Blistering occurs all over the body in Generalized EB Simplex. Blistering only occurs in areas that receive the most trauma, usually the hands and feet, in the more common Localized EB Simplex.
Junctional EB is an autosomal recessive condition that is caused by mutations in the genes that code for collagen 17 or laminin 5. Collagen 17 and laminin 5 are proteins that help anchor the skin together. Without them, the skin separates easily, causing blisters.
Because this disease is autosomal recessive, parents can carry the genetic mutations and be completely healthy. Affected patients receive one copy of the abnormal gene from each parent (see "How is EB inherited?" below).
There are many types of Junctional EB, and all of them cause widespread blistering. Some forms of Junctional EB improve as the patient gets older. A rare form of Junctional EB can be fatal in infancy.
Dystrophic EB is caused by a mutation in the collagen 7 gene and can be dominant or recessive. The collagen gene codes for the collagen 7 protein that anchors the deeper layer of skin (dermis) to the superficial layer of skin (epidermis). When an individual has an abnormal collagen protein, the skin is fragile and separates easily, forming blisters.
Both dominant and recessive forms of Dystrophic EB cause scarring. An individual with dominant Dystrophic EB generally experiences mild to moderate blistering of the skin, but only a small amount of blistering of the mouth, esophagus, and GI tract. This type rarely causes a deformity of the hands or feet caused by the fusion of the fingers or toes (pseudosyndactyly).
Recessive Dystrophic EB is the most severe, chronic type of EB. Blistering begins at birth or shortly afterwards. Much of the skin is covered in blisters and there is extensive internal blistering. Children can develop deformities caused by the recurrent scarring of the fingers and toes (pseudosyndactyly) and the hands and arms become fixed in stiff positions (contractures). It is painfully difficult for a child with recessive Dystrophic EB to ingest food due to the internal blistering that occurs in the mouth, esophagus, and gastrointestinal tract.
Kindler syndrome is an extremely rare form of EB that has features of skin blistering and sensitivity to the sun.
EB is passed to a child from the mother and/or father's chromosomes. All of the genes that cause EB are autosomal, meaning the genes are not carried on the sex-determining (X and Y) chromosomes. Chromosomes are two sets of instruction manuals that contain information on how to make everything in your body. One instruction manual is from your mother and the other is from your father. Genes on chromosomes are like pages or sections of the instruction manual that focus on a specific part of the body, like eye color.
In individuals with EB, some of the pages (genes) of one or both instruction manuals (chromosomes) are missing or incorrect. These pages should contain the instructions to make the proteins that hold the skin together. Faulty instructions lead to missing or abnormal proteins, and the skin is not as strong as it should be. One or two sets of bad instructions produce different forms of EB.
Most forms of EB Simplex and Dominant Dystrophic EB are autosomal dominant - only one abnormal gene is needed to produce disease. The abnormal gene is able to disrupt the function of the normal gene.
A person with a dominant form of EB has a 50% chance in each pregnancy of passing the disease on to their child.
A person may have a dominant form of EB and not have an affected parent. In these cases, a new mutation in the egg or sperm of one parent occurred.
All forms of Junctional EB and Recessive Dystrophic EB are autosomal recessive - two abnormal genes are needed to produce disease.
A carrier has one abnormal copy of the gene for the disease and is completely healthy. If a carrier has a child with another carrier for the same disease, their child may be affected. When two carriers for a disease produce a child, there is a:
This information is most useful to parents who have had one child with a recessive form of EB in determining their risk of having another affected child in the future.
Connect with us:
Download our App: